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Green tea and coffee consumption have been widely popular worldwide. These beverages
contain caffeine to activate the central nervous system by adenosine receptor blockade,
and due to the caffeine, addiction or tolerance may occur. In addition to this caffeine effect,
green tea and coffee consumption have always been at the center of discussions about
human health, disease, and longevity. In particular, green tea catechins are involved in
many biological activities such as antioxidation andmodulation of various cellular lipid and
proteins. Thus, they are beneﬁcial against degenerative diseases, including obesity, cancer,
cardiovascular diseases, and various inﬂammatory diseases. Some reports also suggest that
daily consumption of tea catechins may help in controlling type 2 diabetes. However, other
studies have reported that chronic consumption of green tea may result in hepatic failure,
neuronal damage, and exacerbation of diabetes, suggesting that interindividual variations
in the green tea effect are large. This review will focus on the effect of green tea catechins
extracted from the Camellia sinensis plant on type 2 diabetes and obesity, and the possi-
ble mechanistic explanation for the experimental results mainly from our laboratory. It ishoped that green tea can be consumed in a suitable manner as a supplement to prevent the
development of type 2 diabetes and obesity.
© 2014 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access1. Introduction
Green tea is now consumed everywhere as a beverage and is a
remedy to prevent some degenerative diseases. However, the
effectiveness of green tea consumption on diseases has not
been clearly demonstrated in humans, althoughmany animal
experiments have shown positive results. Green tea extract
(GTE) has many naturally occurring biological components
of which polyphenolic epicatechins (ECs) are predominantly
active (Fig. 1). These include (–)-epigallocatechin-3-gallate
(EGCG), (–)-epigallocatechin (EGC), (–)-epicatechin-3-gallate
(ECG), and (–)-EC. The EC and EGC are catechol catechins, EGC
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2213-4220/© 2014 Korea Institute of Oriental Medicine. Published by Else
(http://creativecommons.org/licenses/by-nc-nd/4.0/).article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
and EGCG are pyrogallol catechins, and ECG and EGCG are gal-
late catechins. This review focuses on the effect of EGCG on
diabetes and obesity. The ﬁrst section describes the overall
effect of EGCG on diabetes and obesity, and the second part
is an analysis of the effect of EGCG on degenerative metabolic
diseases.
2. Overall conception of the effect of EGCGity School of Medicine, 1095 Dalgubeoldae-Ro, Dalseo-Gu, Daegu
on diabetes and obesity
Daily consumption of green tea by patients with dia-
betes for several months is ineffective for ameliorating
vier. This is an open access article under the CC BY-NC-ND license
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various GLUTs. In addition, there are signiﬁcant interindivid-
ual variations in blood concentrations of EGCG after green
tea ingestion,19,20 suggesting that there are difﬁculties in
Table 1 – Species variation in the amount of EGCG to be
absorbed into circulation after IG ingestion of EGCG*
IG ingestion
of EGCG
Blood
concentrations
Refs
Rat 75mg/kg 35nM 21
Mouse 75mg/kg 280nM 22
Human 2mg/kg 170nM 20
525mg inGTE/man 4.4M 19Fig. 1 – Naturally occurring ca
iabetes-related parameters, including blood glucose levels,
bA1C levels, insulin resistance, and inﬂammation markers.1
any randomized trials2–6 support this result of Fukino et al.1
owever, some retrospective cohort studies in Japan7 and
aiwan8 suggest that green tea is effective against type 2 dia-
etes.
Those studies revealed that EGCG, the most abundant
orm of catechin in green tea, inhibits adipocyte prolifera-
ion and differentiation,9–11 increases cellular defense against
xidative stress,12 and blocks sodium-dependent glucose
ransporter 1 (SGLT1)13 and lipid micelle formation14 in the
ntestine. However, the concentrations of EGCG required to
ecrease the number of preadipocytes and adipocytes are too
igh to be consumed by humans without considerable side
ffects.15–17 Although green tea catechins have the molecular
tructure to scavenge oxygen-free radicals, their effectiveness
n biological systems has not been clariﬁed. Some reports
emonstrate that EGCG is a pro-oxidant and harmful for
eta-cell survival in streptozotocin-induced diabetic rats.18
lockage of SGLT1 and lipid micelle formation is the most
mportant and strongest mechanism for gallate catechins
o exert their effects against obesity and diabetes. However,
here is a limitation to use gallate catechins as a remedy
or these two metabolic diseases. A lower concentration of
allate catechins than those that block SGLT1 blocks sodium-
ndependent glucose transporters (GLUTs) in various tissues.
lthough dietary glucose absorption into the circulation is
ainly performed by intestinal SGLT1 as well as by some
LUTs, cellular glucose uptake as an energy source in most
ells is performed by insulin-dependent (GLUT4) and insulin-
ndependent GLUTs. Maximum blood EGCG concentrationsins extracted from green tea.
are achieved 90minutes after green tea ingestion and con-
siderable concentrations of EGCG are present in circulation
for 3–4hours. This means that the effects of EGCG in the
alimentary tract remain only for 1 hour, but the effects in cir-
culation remain for several hours. Blocking cellular glucose
uptake during the postprandial period resembles insulin resis-
tance, eventually leading to failure of beta cells to secretemore
insulin.
The discrepancy among human epidemiological data for
the antidiabetogenic effects of green tea catechins can be
attributed to several reasons. As shown in Table 1, one cup of
green tea contains approximately 100mgEGCG in 1gGTE. This
quantity easily makes blood concentrations of EGCG about
100nM in a fasting state, and a concentration that can inhibit∗ Acupof green tea contains approximately 100mgEGCG in 1gGTE.
EGCG, (–)-epigallocatechin-3-gallate; GTE, green tea extract; IG,
intragastric.
6controlling EGCG concentration in experiments involving
humans, as the meals make absorption of the GTE slower.
By contrast, animal experiments are more controllable and
show that rats21 have the lowest oral bioavailability of EGCG
compared with mice22 and humans (Table 1); in fact, the oral
bioavailability of EGCG is lower in mice than that in humans.
Therefore, during animal experiments, oral ingestionofGTEor
EGCG only shows the intestinal effects but not the effect in cir-
culation. Thus, the resultsmay bemore interpreted as positive
results against obesity and diabetes than those obtained from
humans. Therefore, to extend the intestinal effects of EGCG
and to decrease the circulatory effect of EGCG, entry of EGCG
into circulation should be blocked, at least for using EGCG to
treat type 2 diabetes and obesity.
3. EGCG effect in metabolic tissues
3.1. How much green tea should we take for the
intestinal effect of EGCG?
Kobayashi et al13 found that the 50% inhibitory concentration
(Ki) of ECG to block 50% of rabbit intestinal glucose uptake was
390M. Park et al23 reported that the 50% inhibition of glu-
cose uptake was around 100M for EGCG in the human colon
adenocarcinoma CACO-2 cells, whereas an inhibitory effect
was observed at 10M. Concentrations of EGCG > 100M are
necessary to block lipid micelle formation.14 Raederstorff14
further found that 500-mg EGCG/kg body weight is neces-
sary to inhibit 50% cholesterol absorption in rats. Park et al24
reported that the EGCG effect can be potentiated if EGCG is
applied as a constituent of an intact GTE, as other GTE con-
stituents protect EGCG fromdegradation or ECGadds the same
effect as EGCG. Use of GTE, not EGCG, is a means to reduce the
amount of EGCG used. GTE containing at least 100mg EGCG
Table 2 – Dose-dependent effects of EGCG
Functions Concentrations,
SGLT1 block >1
GLUTs block <1
Micelle formation block >100
Alcohol absorption block >100
In KATP channels
PIPs sensitivity block <1
ATP sensitivity block >1
Direct channel block >10
In adipocytes
Increased RBP-4 secretion >1
Increased ROS generation >10
Decreased adipocyte survival >10
Decreased PPAR- expression >10
Decreased adiponectin expression >10
ATP, adenosine triphosphate; ECG, (–)-epicatechin-3-gallate; EGC, (–)-epi
chin; GLUTs, glucose transporters; KATP, ATP-sensitive K+; PIPs, phosphatid
receptor-; RBP-4, retinol binding protein-4; ROS, reactive oxygen species;Integr Med Res ( 2 0 1 4 ) 4–10
may be necessary to exert an effect on SGLT1 and lipidmicelle
formation in the gastrointestinal tract.23–25 Fortunately, this
levelwould not block amino acid and polypeptide transporters
in the intestine.13 Therefore, it would be sufﬁcient to have one
cup of green tea just prior to a meal. However, as shown in
Tables 1 and 2, plasma concentrations of EGCG could easily
reach 100nM with normal daily consumption of green tea,
which is a concentration that would inhibit various GLUTs in
tissues and lead to a shortage of glucose in cells. This is a bur-
den on beta cells and glucose-deﬁcient cells to decrease blood
glucose levels during the postprandial period.
3.2. EGCG on oxidative stress
Cell viability is impaired signiﬁcantly when preadipocytes are
treated with 50M EGCG, but recover by treatment with the
antioxidant vitamin E.15 This means that this concentration
of EGCG may act as a pro-oxidant.18 Low cell viability was
not observed until the concentration of EGCG is 10M. These
phenomena are also true for mature adipocytes; when 50M
but not 10M EGCG was applied for 4 days during the early
3T3-L1 adipocyte differentiation (Days 0–3) or during the mat-
uration period (Days 4–7), cell viability and cellular triglyceride
accumulation decreased, and intracellular reactive oxygen
species (ROS) accumulation increased. This ROS accumula-
tion caused by EGCG may be linked to the gallate moiety in
the EGCG molecule, as catechin does not possess the gallate
moiety and has no effect on intracellular ROS concentrations.
At the concentration that EGCG increases intracellular ROS
concentrations, the expression of peroxisome proliferator-
activated receptor- is downregulated in mature adipocytes,
26,27correspondingly downregulating adiponectin. In addition,
the expression of retinol binding protein-4 (RBP-4) is upre-
gulated. The increased expression of RBP-4 due to 50M
EGCG was partially but not totally recovered by co-treatment
M Refs Catechins
23 <ECG
13 (only GC)
24 <ECG
39 (only GC)
16
40
14 ≈ECG (probably)
23 ≈ECG
(only GC)
48 only EGCG
48 only EGCG
46 >EGC, <ECG
15 >ECG
15 >ECG
15 >ECG
15 >ECG
15 >ECG
gallocatechin; EGCG, (–)-epigallocatechin-3-gallate; GC, gallatecate-
ylinositol polyphosphates; PPAR-, peroxisome proliferator-activated
SGLT1, sodium-dependent glucose transporter 1.
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ith vitamin E and EGCG, suggesting that increased ROS
eneration could be a factor for EGCG-inducedRBP-4upregula-
ion. The increased expression of RBP-4 after EGCG treatment
as further recovered by co-treatment of methyl pyruvate
ith vitamin E, which is a cellular energy source bypass-
ng GLUTs and glycolysis, suggesting that impaired glucose
ptake by EGCG was also a causative mechanism for RBP-4
pregulation. Secretion of RBP-4 in human adipocytes consis-
ently increased with 10M EGCG, which is lower than the
0M EGCG required to induce intracellular ROS accumu-
ation. This observation suggests that the ROS-independent
echanism to block glucose uptake can be another critical
actor to increase RBP-4 expression and secretion. Thus, long-
erm application of lower EGCG concentrations could increase
BP-4 signaling. The EGCG concentration dependency of intra-
ellular ROS accumulation in adipocytes in our study was
onsistent with other ﬁndings.9,11,28,29 Unfortunately, EGCG-
nduced ROS generation at the higher EGCG concentration
oes not show tissue speciﬁcity.17,30–32 If it was tissue spe-
iﬁc, it would be useful for obesity to target only adipocytes
r for certain localized cancers. In addition, higher concentra-
ions of EGCG are not achievable in human plasma without
onsiderable adverse effects.33 Therefore, the pro-oxidative
ature of high concentrations of EGCG is not an acceptable
echanism to protect against obesity and even cancers. There
re reports34 describing EGCG concentration dependency in
he EGCG–oxidative stress relationship; nanomolar concen-
rations of EGCG have an antioxidant action and micromolar
oncentrations of EGCG have a pro-oxidant action. However,
he pro-oxidative activity of EGCG can occur at concentra-
ions < 50M, even at about 1M concentration in the beta
ells damaged previously by streptozotocin18 or hippocam-
al neuronal cells.17 This suggests that EGCG always induces
OS stress in cells that would not occur if the cell’s scav-
nging systems are intact. Therefore, EGCG action against
xygen-free radicals may be altered by the kinds of radi-
al stimulants, cellular conditions, and the exposed time to
GCG. Green tea catechins can exert their effect as both pro-
xidants and antioxidants;12,35 the presence of the gallate
G) ring, the catechol (C) ring, the pyrogallol (P) ring, or the
esorcinol (R) ring is important for the antioxidant activities
f catechins12 (Fig. 1). In addition, the P ring is also impor-
ant for the antifungal action of catechins.36 The pro-oxidative
ctivity of catechins is attributed to their potency from auto-
xidation andperoxidase-catalyzed oxidation.37 As previously
oted, the potency of increasing ROS in adipocytes is EGCG >
CG, but not nongallate catechins, of which EGCG has both
yrogallol and gallate moieties.
.3. EGCG on cellular glucose uptake
e think that a critical factor to increase RBP-4 secretory
ignaling from mature adipocytes is the effect of EGCG to
ecrease cellular glucose uptake. It is well known that cellular
lucose uptake in various tissues is impaired in the insulin-
esistance state, making beta cells secrete more insulin and
ausing early beta-cell exhaustion throughout life. Impaired
lucose uptake by EGCG can be observed at EGCG concentra-
ions < 10M.38 Park et al24 also showed that EGCG inhibits
ellular glucose uptake at 100nM inmyocytes, adipocytes, and7
beta cells, and 1M in hepatocytes, which is easily achievable
in human plasma by oral intake of two to three cups of green
tea24 (Table 1). These ﬁndings are consistent with the results
obtained in other tissues by previous observations,16,39,40 sug-
gesting that most tissues possessing either of various GLUTs
can be hindered with glucose use in the presence of EGCG.
The adipokine RBP-4 is secreted frommature adipocyteswhen
adipocytes detect deﬁcient glucose uptake.41 In the fasting
state, secretion of RBP-4 stimulates hepatic glucose output
and inhibits muscular glucose uptake,42 probably to spare
blood glucose levels. Therefore, abnormally increased expres-
sion and secretion of RBP-4 may elicit insulin resistance. It
would be difﬁcult to normalize blood glucose levels by insulin
during the postprandial period if plasma EGCG hinders most
tissues to uptake glucose. This action of EGCG on GLUTs may
be related to its gallate moiety, because ECG and genistein
also have a blocking effect toward GLUTs, and ECG is the
more potent.31,39 The mechanism of EGCG to inhibit cellular
glucose uptake may be either blockade of insulin signaling
or direct competition with glucose for GLUTs.16,43 We found
that insulin-induced Ser473 phosphorylation of protein kinase
B remained unchanged in the presence of EGCG in hepato-
cytes, adipocytes, myocytes, and beta cells.24 The impact of
this EGCG action on cellular glucose uptake can be observed
in vivo and we found that EGCG at about 1M in blood acutely
elevates blood glucose and insulin levels during the oral glu-
cose tolerance test (OGTT) in humans.24 It conﬁrms that daily
intake of green tea is clinically relevant. We orally applied
GTE-containing EGCG at about 100mg to selected human par-
ticipants either immediately or 1 hour prior to oral glucose
ingestion for the OGTT. In the former case, blood glucose lev-
els during the OGTT were maintained lower than the control
without GTE ingestion. However, in the latter, blood glucose
and insulin levels were greater than those in the control. In
addition, greater insulin resistance was observed during the
insulin tolerance test. This ﬁnding was also true for ECG,
and a gallate catechin-free GTE would not exert this effect.
This result clearly suggests that absorbed gallate catechins,
mainly EGCG and ECG, hinder cellular glucose uptake in
insulin-sensitive tissues during the OGTT and thus increase
insulin secretion from beta cells. This phenomenon occurring
by ingesting the GTE is well matched with the postprandial
period in prediabetes with insulin resistance and overt type 2
diabetes. We further conﬁrmed that this EGCG action was not
associated with the effect of EGCG on adenosine triphosphate
(ATP)-sensitive K+ (KATP) channels because it occurred even in
KATP channel-deﬁcient mice.
3.4. Direct KATP channel modulation of EGCG
The plasmalemmal KATP channel is an octamer that includes
four inwardly rectifying potassium (Kir)6.2 and four sul-
fonylurea receptors (SURs). EGCG inhibits the activity of
Kir6.2/SUR1 (beta-cell type) inXenopusoocytes expressingKATP
channels, with an inhibitory concentration 50 (IC50) of about
140M, which is also observed in Kir6.2/SUR2A (cardiac type)
and Kir6.2/SUR2B (vascular type). The inhibitory potency of
EGCG was similar to the IC50 of EGCG for voltage-dependent
potassium (Kv) 1.5 channels (101M).44 ECG is three times
more effective for this inhibition than EGCG, and nongallate
Integr Med Res ( 2 0 1 4 ) 4–10
Table 3 – Structure–function relationships of green tea
catechins
Functions Structures Refs
SGLT1 block G ring
GLUTs block G ring
Alcohol absorption block G ring
In KATP channels
PIP sensitivity block G ring + P ring
ATP sensitivity block G ring + P ring
Direct channel block G ring + C ring > G ring + P ring
ROS generation G ring + P ring > G ring + C ring
ROS scavenging G ring, C ring, P ring, and R ring 12
Antifungal action P ring 36
ATP, adenosine triphosphate; C ring, catechol ring; G ring, gal-
late ring; GLUTs, glucose transporters; KATP, ATP-sensitive K+; P
ring, pyrogallol ring; PIPs, phosphatidylinositol polyphosphates; R
ring, resorcinol ring; ROS, reactive oxygen species; SGLT1, sodium-8
catechins did not have any effect. The IC50 of EGCG for channel
inhibition was about 20M with Kir6.2C36 channels, which
are the channel pore-forming subunits. The absence of the
SUR subunits suggests that the regulatory subunit SUR may
hinder the inhibitory action of EGCG on Kir6.2. The principal
mechanism for Kir6.2 blockade of gallate catechins may be
due to the interaction between EGCG and ECGwith lipid bilay-
ers embedded in the KATP channels, because the interaction of
catechins with lipids is stronger when the catechol ring and
gallate ring are both present as in ECG.45 A small contribu-
tion of the pyrogallol ring is also detected45 because EGC can
inhibit KATP channels, but only slightly.46
3.5. EGCG-induced change in KATP channel sensitivity
to phosphatidylinositol polyphosphates and ATP
The KATP channel activity is inhibited by ATP through the
Kir6.2 subunit and activated by MgADP through the SUR
subunit.47 Phosphatidylinositol polyphosphates (PIPs) such as
PIP2 and PIP3 activate the channel through the Kir6.2. The
KATP channels play crucial roles in glucose-stimulated insulin
secretion in beta cells and protect cardiac myocytes from
metabolic inhibition. Although direct KATP channel inhibition
was accomplished by gallate catechins such as EGCG and ECG,
the reducing effect of the GTE on KATP channel ATP and PIP
sensitivity only occurred in EGCG, which additionally has the
hydroxyl group (–OH) on the pyrogallol moiety.48 The ATP sen-
sitivity of the KATP channel in the presence of 10M EGCG
was 10 times less than that in the absence of EGCG (13.4M
vs. 120M). EGCG did not eliminate the bound ATP molecules
from the channels but inhibited channel binding of ATP. The
adenosinemonophosphate (AMP) and adenosine diphosphate
blocks for KATP channels were not hindered by EGCG. The
-phosphate tail of ATP is bound to R50 in the N terminal
of Kir6.2, and ATP binding to Kir6.2 is facilitated by incor-
porating SUR1. Our results show that EGCG may inhibit the
Fig. 2 – Schematic representation of gallated catechins inhibiting
glycol-3350 or poly--glutamate blocks absorption of gallate cate
the molecules; unbroken arrow line represents facilitation by ins
chylomicron; F, dietary fat; G, glucose; GC, gallate catechins; M, mdependent glucose transporter 1.
facilitating function of SUR1. Moreover, the decrease in the
channel PIP sensitivity caused by EGCG appears even at 1M
EGCG. This may have occurred due to direct hindrance of the
PIP interactionswith their binding sites onKir6.2 by EGCG. The
mechanism may be due to the negative charges of EGCG and
the positive charges on the PIPs binding sites of the channels
against the negative charges of PIPs. It would require a serious
involvement of EGCG in KATP channel gating kinetics if the two
major modulators ATP and PIPs have a limitation to play their
actions.
4. Concluding remarks and future
perspectivesThe effects of EGCG regarding diabetes and obesity are sum-
marized in Table 2 and the related molecular structures of
glucose uptake and micelle formation. Polyethylene
chins into circulation. Broken lines represent movement of
ulin; unbroken block lines represent inhibition by GC. C,
icelle.
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GCG are shown in Table 3. The antioxidative effects of
reen tea can be a substitute for other well-known antioxi-
ants. Blockage of adipocyte differentiation and proliferation
y EGCG is not possible in humans because intolerable plasma
oncentrations of EGCG are required. Animal data consid-
ring the effect of EGCG on obesity and diabetes cannot be
eplicated in humans because of different oral bioavailability
mong species. Green tea intake to exert beneﬁcial intesti-
al effects sufﬁciently elevates blood EGCG levels to inhibit
ellular glucose uptake. Many previous in vitro experimen-
al data show the downstream phenomena for the effect
f EGCG on inhibiting cellular glucose uptake, such as ele-
ated AMP-activated protein kinase activity. EGCG may be
ffective for cancer protection due to its inhibitory action
n cancer-cell glucose utilization, but not by direct modu-
ation of speciﬁc cellular signaling. Blocking the absorption
f green tea gallate catechins, which block cellular glucose
ptake in the circulation, may be a clue for green tea use
gainst diabetes and obesity. This also means prolongation of
heir effects in the intestine. Polyethylene glycol-3350 or poly-
-glutamate dramatically and selectively block entry of gallate
atechins into circulation, prolonging their intestinal effects
Fig. 2).23–25 Human clinical trials should proceed to develop
safer treatment tool against type 2 diabetes and related
besity.
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